Treatment and prevention of invasive pneumococcal disease

被引：7
作者：
Dominguez-Alegria, A. R. [1 ]
Pintado, V. [2 ]
Barbolla, I. [1 ]
机构：
[1] Hosp Ramon & Cajal, Serv Med Interna, Madrid, Spain
[2] Hosp Ramon & Cajal, IRYCIS, Serv Enfermedades Infecciosas, Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 05期
关键词：
Streptococcus pneumoniae; Invasive pneumococcal disease; Resistance; Combined therapy; Vaccine; COMMUNITY-ACQUIRED PNEUMONIA; COMBINATION ANTIBIOTIC-THERAPY; RESISTANT STREPTOCOCCUS-PNEUMONIAE; VACCINE-NAIVE ADULTS; POLYSACCHARIDE VACCINE; ANTIMICROBIAL RESISTANCE; CONJUGATE VACCINE; CEFTOBIPROLE MEDOCARIL; BACTEREMIC PNEUMONIA; CEFTAROLINE FOSAMIL;
D O I：
10.1016/j.rce.2018.01.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Invasive pneumococcal disease is a severe infection that mainly affects patients with associated comorbidity. The paediatric conjugate vaccination has resulted in a change in the adult vaccination strategy. The antibiotic resistance of pneumococcus is not currently a severe problem. Nevertheless, the World Health Organisation has included pneumococcus among the bacteria whose treatment requires the introduction of new drugs, such as ceftaroline and ceftobiprole. Although the scientific evidence is still limited, the combination of beta-lactams and macrolides is recommended as empiric therapy for bacteraemic pneumococcal pneumonia. (C) 2018 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码：244 / 252
页数：9
相关论文
共 79 条
  • [1] Abdelraouf K, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01957-16, 10.1128/aac.01957-16]
  • [2] Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
    Andrews, Nick J.
    Waight, Pauline A.
    George, Robert C.
    Slack, Mary P. E.
    Miller, Elizabeth
    [J]. VACCINE, 2012, 30 (48) : 6802 - 6808
  • [3] [Anonymous], 2017, WHO | Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics
  • [4] Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
    Aspa, J
    Rajas, O
    de Castro, FR
    Huertas, MC
    Borderías, L
    Cabello, FJ
    Tábara, J
    Hernández-Flix, S
    Martinez-Sanchis, A
    Torres, A
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (05) : 1010 - 1019
  • [5] A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
    Awad, Samir S.
    Rodriguez, Alejandro H.
    Chuang, Yin-Ching
    Marjanek, Zsuszanna
    Pareigis, Alex J.
    Reis, Gilmar
    Scheeren, Thomas W. L.
    Sanchez, Alejandro S.
    Zhou, Xin
    Saulay, Mikal
    Engelhardt, Marc
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (01) : 51 - 61
  • [6] Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors
    Backhaus, Erik
    Berg, Stefan
    Andersson, Rune
    Ockborn, Gunilla
    Malmstrom, Petter
    Dahl, Mats
    Nasic, Salmir
    Trollfors, Birger
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [7] Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
    Baddour, LM
    Yu, VL
    Klugman, KP
    Feldman, C
    Ortqvist, A
    Rello, J
    Morris, AJ
    Luna, CM
    Snydman, DR
    Ko, WC
    Chedid, MBF
    Hui, DS
    Andremont, A
    Chiou, CCC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (04) : 440 - 444
  • [8] Prognostic factors associated with mortality and major in-hospital complications in patients with bacteremic pneumococcal pneumonia Population-based study
    Beatty, Jessica A.
    Majumdar, Sumit R.
    Tyrrell, Gregory J.
    Marrie, Thomas J.
    Eurich, Dean T.
    [J]. MEDICINE, 2016, 95 (46)
  • [9] In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China
    Biedenbach, D. J.
    Bouchillon, S. K.
    Johnson, B.
    Alder, J.
    Sahm, D. F.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (12) : 1933 - 1939
  • [10] Understanding the burden of pneumococcal disease in adults
    Blasi, F.
    Mantero, M.
    Santus, PierAchille
    Tarsia, P.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 : 7 - 14
12345678